France: Dr Molly Ingersoll received her PhD from NYU School of Medicine, where she studied host–pathogen interactions with Arturo Zychlinsky at both NYU and the Max Planck Institute for Infection Biology in Berlin, Germany. She completed a brief postdoctoral fellowship at Washington University School of Medicine in St Louis, Missouri, focusing on innate immunity to urinary tract infections with Scott Hultgren, followed by a postdoctoral appointment at Mount Sinai Medical Center in New York City, where she investigated monocyte and dendritic cell biology.
Dr Ingersoll is currently a Research Director with a joint appointment at Institut Cochin and Institut Pasteur in Paris. Her team explores mucosal immunity in the bladder in the context of infection and cancer, with a focus on understanding the influence of biological sex on bladder responses to both infectious and non-infectious inflammatory diseases. She aims to develop immunomodulatory strategies to improve disease outcomes.
